INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAB4. A total of 12 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $803,000 | -52.2% | 1,250,000 | -55.8% | 0.03% | -48.4% |
| Q4 2020 | $1,681,000 | -14.1% | 2,825,000 | 0.0% | 0.06% | -30.4% |
| Q3 2020 | $1,957,000 | -60.7% | 2,825,000 | -58.6% | 0.09% | -67.4% |
| Q2 2020 | $4,985,000 | +46.2% | 6,825,000 | +78.4% | 0.28% | +4.8% |
| Q1 2020 | $3,410,000 | -45.9% | 3,825,000 | -19.5% | 0.27% | -22.9% |
| Q4 2019 | $6,304,000 | +21.0% | 4,750,000 | -17.4% | 0.35% | +4.2% |
| Q3 2019 | $5,208,000 | -32.5% | 5,750,000 | -25.8% | 0.34% | -24.4% |
| Q2 2019 | $7,713,000 | – | 7,750,000 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 55,943,000 | $34,742,000 | 1.33% |
| PenderFund Capital Management Ltd. | 5,000,000 | $3,839,000 | 0.98% |
| Context Capital Management, LLC | 7,485,000 | $4,494,000 | 0.62% |
| Opti Capital Management, LP | 7,000,000 | $4,250,000 | 0.47% |
| Soros Fund Management | 32,298,000 | $19,611,000 | 0.37% |
| Shaolin Capital Management LLC | 7,000,000 | $4,175,000 | 0.29% |
| Weiss Asset Management LP | 3,500,000 | $2,084,000 | 0.09% |
| CSS LLC/IL | 2,825,000 | $1,681,000 | 0.06% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 225,000 | $137,000 | 0.02% |
| LAZARD ASSET MANAGEMENT LLC | 25,000,000 | $15,009,000 | 0.02% |